Search

Author/Creator Kay, Gary G.

1. A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopiclone. (June 2015)

Authors:
Simen, Arthur A.; Gargano, Cynthia; Cha, Jang-Ho; Drexel, Melissa; Bautmans, An; Heirman, Ingeborg; Laethem, Tine; Hochadel, Thomas; Gheyle, Lien; Bleys, Kim; Beals, Chan; Stoch, Aubrey; Kay, Gary G.; Struyk, Arie
Journal:
Therapeutic advances in drug safety
Issue:
Volume 6:Number 3(2015:Jun.)
Page Start:
86
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Early‐stage comparative effectiveness: Randomized controlled trial with histamine inverse agonist MK‐7288 in excessive daytime sleepiness patients. (4th October 2013)

Authors:
Sun, Hong; MacLeod, Catherine; Mostoller, Kate; Mahon, Chantal; Han, Lingling; Renger, John J.; Ma, Junshui; Brown, Kevin R.; Schulz, Valerie; Kay, Gary G.; Herring, W. Joseph; Lines, Christopher; Rosen, Laura B.; Murphy, M. Gail; Wagner, John A.
Journal:
Journal of clinical pharmacology
Issue:
Volume 53:Number 12(2013:Dec.)
Page Start:
1294
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Next‐day residual effects of gabapentin, diphenhydramine, and triazolam on simulated driving performance in healthy volunteers: a phase 3, randomized, double‐blind, placebo‐controlled, crossover trial. (28th March 2016)

Authors:
Kay, Gary G.; Schwartz, Howard I.; Wingertzahn, Mark A.; Jayawardena, Shyamalie; Rosenberg, Russell P.
Journal:
Human psychopharmacology
Issue:
Volume 31:Number 3(2016:Apr.)
Page Start:
217
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗